Shared Decision-Making in Allergen Immunotherapy

Purpose: The objective of this study was to develop and validate a questionnaire, through a Delphi consensus, to be used by allergists in their routine clinical practice to assess the preferences of patients starting allergen immunotherapy (AIT) treatment using an objective approach. Patients and Me...

Full description

Saved in:
Bibliographic Details
Published in:Patient preference and adherence 2023-07, Vol.17, p.1771
Main Authors: Vidal, Carmen, Letran, Antonio, Montoro, Javier, Jimenez-Ferrera, Gloria, Mur-Gimeno, Pilar, Vega-Chicote, Jose M.A, Cabanes, Nieves, Mendez-Brea, Paula, Rodrfguez-Vazquez, Virginia, Anton, Monica, Rosado, Ana, Sanchez-Guerrero, Inmaculada, Fernandez-Nieto, Mar, Fernandez-Melendez, Salvador, Moreno, Francisco
Format: Article
Language:English
Subjects:
Allergic reaction
Allergy
Care and treatment
Complications and side effects
Decision-making
Health aspects
Immunotherapy
Patient outcomes
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Purpose: The objective of this study was to develop and validate a questionnaire, through a Delphi consensus, to be used by allergists in their routine clinical practice to assess the preferences of patients starting allergen immunotherapy (AIT) treatment using an objective approach. Patients and Methods: A Delphi consensus-driven process was used. The scientific committee, composed of 15 allergists, led the study and participated in the preparation of the questionnaire. Two-hundred panelists from different Spanish regions were invited to complete a 16-item questionnaire on a nine-point Likert scale covering six topic blocks. Consensus was achieved if [greater than or equal to]66.6% of panelists reached agreement or disagreement. Results: Of the 200 experts invited to participate in the Delphi process, a total of 195 (97.5%) answered the questionnaire. The panel experts reached a consensus on "agreement" on a total of 12 of the 16 (75.0%) items, covering a total of six categories: (a) patient knowledge (2 questions), (b) barriers to patient adherence (3 questions), (c) patient behavior (4 questions), (d) future actions (3 questions), (e) treatment costs (2 questions), and (f) final patient preferences (2 questions). Conclusion: This Delphi consensus study validated a set of twelve recommended questions for patients objectively assessing their preferences and suitability for the most common AIT options available. The questionnaire intends to assist allergists in making an objective, unconditioned decision regarding the best AIT option for each patient, after informing them about the different routes. Keywords: allergen immunotherapy, Delphi consensus, shared decision-making, questionnaire
ISSN:1177-889X
1177-889X